Stock Price & Analysis

Could you please specify which stock you are asking about?

The current price of A Stock is 120.51 as of 2025-03-25. Based on market expectations, the price could reach 125 by the end of 2025, driven by positive earnings reports and strong sector performance.

The S1 support level for A Stock is $114.13 ,The R1 resistant level for A Stock is $123.06.

As of the end of day on 2025-04-02, the price of A Stock was $113.

The target price for A Stock according to analyst rating is 153.17, with the highest price target at 160.00 and the lowest at 138.00. Analysts have a Moderate Buy rating on A Stock overall.

The market cap of A is $33.1B.

Analysis and Insights

Agilent Technologies (A) appears to be overvalued based on several key metrics and analysis:

1. Valuation Metrics:

   • The stock has a high P/E ratio of 34.8 and EV/EBITDA of 24.79, both significantly above industry averages, indicating a premium valuation.
   • The price-to-sales (P/S) ratio of 6.7 and price-to-book (P/B) ratio of 7.17 further suggest overvaluation compared to peers.

2. Revenue and Profitability:

   • While Q1 2025 revenue showed a slight increase to $1.7 billion, it fell short of expectations, raising concerns about growth momentum.
   • Net income has been inconsistent, with Q4 2024 net income at $351 million, down from $348 million in Q1 2024.

3. Analyst Sentiment:

   • Analysts have mixed opinions, with some maintaining a "Hold" rating and others lowering price targets. Baird reduced its target to $159 from $161, citing conservative guidance.

4. Stock Performance:

   • The stock has underperformed the market, trading 21.2% below its 52-week high and below its 50-day and 200-day moving averages.

Conclusion

Agilent's high valuation, inconsistent profitability, and mixed analyst sentiment suggest the stock may be overvalued. Investors should exercise caution and consider waiting for a price correction or improved fundamentals before investing.

Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.

Apple stock is predicted to reach $300 by 2030, driven by its strong AI integration and services growth. The company's focus on emerging markets and AI-driven products positions it for sustained growth. However, this forecast is speculative and depends on execution.

A has a total of 18100 employees.